AI-extracted claim
“Blackstone invested $750 million in the development of Moderna's flu shot”
Analyzed on 2026-09-18T18:42:55+00:00 · Last updated 2026-09-18
Plain language: Insufficient evidence was found to render a verdict.
Credibility score
out of 100
Based on 1 source
Low confidence
Original context
Show passage from source article
Blackstone, the private equity company, had invested $750 million in the development of Moderna’s flu shot, in addition to the vaccine maker’s own support for the large clinical trial, he said.
Extracted from: F.D.A. Refuses to Review Moderna Flu Vaccine , The New York Times
Evidence
This analysis is based on a single source. Confidence is low.
Bias distribution of supporting sources
Mean bias -0.20
Community Takes
No Takes have been written on this claim yet. Sign in to write a Take.